Assessment of Peripheral Neuropathy in Ankylosing Spondylitis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAssiut University
About this trial
investigators hypothesized that peripheral neuropathy in ankylosing spondylitis is associated with higher disease activity, greater central sensitization, worse functional impairment, and poorer quality of life.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Patients aged ≥18 years
Diagnosis of ankylosing spondylitis according to the modified New York criteria (6).
Ability to provide informed consent
Disqualifiers
Patients under the age of 18 years.
Patients with definite diagnosis for any other systemic autoimmune disorders.
Diabetes mellitus
Chronic renal or hepatic disease
Trial population
Patients aged ≥18 years with Diagnosis of ankylosing spondylitis according to the modified New York criteria
Trial design
Design model
Case-only
Time perspective
Cross-sectional
Treatments tested in this trial
Nerve conduction study
Diagnostic testPeripheral neuropathy will be evaluated using nerve conduction studies (NCS) for upper and lower limbs peripheral nerves performed according to standard electrophysiological techniques.
Treatment groups
45 Participants
are divided into 1 treatment groupGroup A: Ankylosing spondylitis Patients1 intervention
Trial outcomes
Primary outcomes
1
presence of peripheral neuropathy
Peripheral neuropathy will be evaluated using nerve conduction studies (NCS) for upper and lower limbs peripheral nerves performed according to standard electrophysiological techniques.
Time frame
1 monthSponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: